Existing regulations involving quality-control (QC) monitoring for biopharmaceutical companies require review of production control records and investigation of issues, including any signs of failures that could affect product sterility. Industry guidelines call for quality data analysis to identify and respond to adverse trends. Visualization and trending tools allow analysts to track adverse trends. As a result, companies must monitor in-process, utility-support systems, and the production environment on a consistent and standard basis (1).
Automated processes provide an electronic representation of the QC program, eliminating many of the clerical steps required in a manual, paper-based system—recording, reconciling, storing, and retrieving information. Compliant and accurate information goes to a QC repository that is available on corporate networks providing comprehensive data on all key monitoring points. Data are immediately available for reporting, trending, and investigative support through a variety of ad hoc analytical and visualization tools, statistical process control software, and other widely used software packages for professionally formatted report output.
Throughout the process, samples are collected containing information such as location, time, product/lot, and equipment traditionally transcribed on paper. Specialized QC software allows this information to be recorded electronically at the point of sample and prevents omission errors through the system by requiring entry of information into each field. It also can automatically fill in correct information where possible and incorporate bar-coded information to further reduce the potential for handwritten errors.
These samples are checked into laboratory storage or equipment such as incubators. The QC software controls which samples can be submitted and their destination points, thereby further reducing the chance of error. To reduce the chance for deviation from a procedure, controls also are in place to manage the duration of incubation/storage.
Samples are tested and results are read. Information is electronically recorded for these steps, and calculations are automatically performed eliminating the risk of calculation error. Results are compared against the alert/action limits by the software and users are notified when a sample is out-of-specification.
Lastly, these samples are ready to be reviewed. Reviewers are able to see all the information recorded during the previous steps, including the task performers. Visual cues specify the samples that are out-of-specification. The data is available for trending. Traditionally, paper information had to be entered into a spreadsheet or database then manually reformatted for trending. The use of QC software allows the user to trend at the click of a button.
A typical paperless QC process starts by scanning a barcode to identify QC sampling requirements at a specific location such as a cleanroom, utility port, or production line. The location at which the sample is taken, media used, equipment used (i.e., total organic carbon apparatus, conductivity meter, and pH meter) is recorded.
Wireless tablet personal computers, barcode scanners, and thermal barcode printers using sterile label stock can be used to perform the mobile data acquisition. Sealed laptop computers can provide the capability to run the specialized QC software as well as other software systems such as document management applications for standard operating procedure (SOP) access within an aseptic production environment. This automated solution component eliminates the risk of introducing shed particles from paper copies and helps to improve overall compliance.
Automation can reduce scheduling, sampling, and associated time for managing the monitoring routines by 35–50%, as reported at Lonza's manufacturing facility for biopharmaceutical products in Walkersville, Maryland. Products range from research reagents to licensed test kits to regulated parenteral products.